-
Diplomat added to limited-distribution network for Cornerstone Therapeutics' Bethkis
FLINT, Mich. — Cornerstone Therapeutics has added specialty pharmacy Diplomat to its limited-distribution network for a newly approved treatment for cystic fibrosis, Diplomat said Friday.
Diplomat will distribute Bethkis (tobramycin inhalation solution), which received Food and Drug Administration approval in October for treating chronic bacterial lung infections caused by P. aeruginosa in cystic fibrosis patients.
-
Teva launches generic ADHD drug
NORTH WALES, Pa. – Teva has introduced a generic version of a drug used to treat attention deficit hyperactivity disorder, the company said Thursday.
The drug maker announced the launch of dexmethylphenidate hydrochloride extended-release capsules, a generic version of Novartis' Focalin XR.
Focalin XR has annual sales of about $202 million, according to IMS Health.